文化大學機構典藏 CCUR:Item 987654321/20906
English  |  正體中文  |  简体中文  |  Items with full text/Total items : 47225/51091 (92%)
Visitors : 13979719      Online Users : 259
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version


    Please use this identifier to cite or link to this item: https://irlib.pccu.edu.tw/handle/987654321/20906


    Title: The Therapeutic Effect of Modified Yu Ping Feng San on Idiopathic Sweating in End-Stage Cancer Patients during Hospice Care
    Authors: Chiu, SC (Chiu, Shih-Che)
    Lai, YL (Lai, Yuen-Liang)
    Chang, HH (Chang, Hen-Hong)
    Chang, KH (Chang, Kou-Hwa)
    Chen, ST (Chen, Shun-Ting)
    Liao, HF (Liao, Hui-Fen)
    Chen, YY (Chen, Yu-Yawn)
    Chen, YJ (Chen, Yu-Jen)
    Contributors: 運教所
    Keywords: NITRIC-OXIDE
    CUTANEOUS VASODILATION
    SHIVERING THRESHOLDS
    VASOCONSTRICTION
    INHIBITION
    MEDICINE
    HUMANS
    SKIN
    Date: 2009-03
    Issue Date: 2011-12-09 10:55:59 (UTC+8)
    Abstract: End-stage cancer patients frequently stiffer from idiopathic sweating of unknown cause. This study was to evaluate the effect (primary endpoint) of modified Yu Ping Feng San on idiopathic sweating and adverse reactions (secondary endpoint). Thirty two end-stage cancer patients receiving hospice care, with exclusion criteria including sweating due to known causes and taking drugs which may affect the sweating threshold were enrolled. Patients received modified Yu Ping Feng San for 10 consecutive days. The quantitative measurement of sweating showed 26 patients (81.3%) had complete remission of sweating, and the average time required to reach 50% reduction was 4.6 days. The visual analog scale (VAS) sweating score estimated by patients and care-givers showed that the mean reductions were 8.4 and 9.1 points, respectively. An increase in appetite was experienced by 65.6% of patients, after administration of modified Yu Ping Feng San. The most prevalent treatment-related complications were nausea (15.6%), diarrhea (9.3%) and allergy (3.1%) without severity greater than grade 2, and these were reversible after cessation of treatment. These results suggest that modified Yu Ping Feng San is a safe and effective treatment for idiopathic sweating of unknown cause in end-stage cancer patients. Copyright (C) 2008 John Wiley & Sons, Ltd.
    Appears in Collections:[Graduate Institute of Sport Coaching Science ] journal articles

    Files in This Item:

    There are no files associated with this item.



    All items in CCUR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback